New analysis suggests GLP-1 drugs could help people living with schizophrenia, another sign of research moving into mental health.
Recap by typeshit. Post by BioWorld on X.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
A busy week in Mexico also covered IMSS workers rejecting a 6.8% raise. GLP-1 drugs get a mention for shifting what people buy to eat.
Retatrutide is still in trials and not FDA approved, she notes, yet some college students are getting it from online sellers anyway.
Loading…